Revance Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $22M | 8.6M | 2.57 |
| 2024-03-31 | $36M | 7.3M | 4.92 |
| 2023-09-30 | $78M | 6.8M | 11.47 |
| 2023-06-30 | $165M | 6.5M | 25.31 |
| 2023-03-31 | $198M | 6.1M | 32.21 |
| 2022-12-31 | $131M | 7.1M | 18.46 |
| 2022-06-30 | $79M | 5.7M | 13.82 |
| 2021-06-30 | $158M | 5.3M | 29.63 |
| 2021-03-31 | $151M | 5.4M | 27.95 |
| 2020-12-31 | $142M | 5.0M | 28.33 |
| 2020-09-30 | $123M | 4.9M | 25.14 |
| 2020-03-31 | $59M | 4.0M | 14.79 |
| 2019-12-31 | $60M | 3.7M | 16.23 |
| 2019-09-30 | $46M | 3.6M | 13.01 |
| 2019-06-30 | $46M | 3.5M | 12.98 |
| 2019-03-31 | $56M | 3.6M | 15.77 |
| 2018-12-31 | $65M | 3.2M | 20.13 |
| 2018-09-30 | $79M | 3.2M | 24.84 |
| 2018-06-30 | $81M | 2.9M | 27.44 |
| 2018-03-31 | $74M | 2.4M | 30.69 |
| 2017-09-30 | $59M | 2.2M | 27.42 |
| 2016-12-31 | $30k | 1.4k | 21.17 |
| 2016-09-30 | $26k | 1.6k | 15.92 |
| 2016-06-30 | $26k | 1.9k | 13.77 |
| 2016-03-31 | $25k | 1.5k | 17.24 |
| 2015-12-31 | $13k | 368 | 35.33 |
| 2015-09-30 | $11k | 368 | 29.89 |
| 2015-06-30 | $12k | 368 | 32.61 |
| 2015-03-31 | $5.0k | 265 | 18.87 |
| 2014-12-31 | $4.0k | 265 | 15.09 |
| 2014-09-30 | $3.0k | 176 | 17.05 |
| 2014-06-30 | $6.0k | 176 | 34.09 |